This is the authors' abstract. We don't add key points for this paper.
The word apoptosis is derived from the ancient Greek and refers to leaves falling. It invokes the idea that death is an integral part of life. It is a stereotypic form of programmed cell death (PCD), distinct from necrosis, which is under tight genetic control (1). This PCD plays an important physiological role in the regulation of cell number within tissues. Knowledge of PCD extends back to the 19th century (2), but it was first recognized as a concept by Lockshin and Williams in 1965 (3). In 1972 Kerr et al. (4) first coined the term apoptosis to describe the morphologic changes of PCD that they saw when using the electron microscope. Gastrointestinal mucosa is characterized by a rapid epithelial cell turnover in which homeostasis is maintained predominantly by apoptosis (5). It is therefore not surprising that inappropriate apoptosis has been implicated in the pathogenesis of a number of gastrointestinal disorders (6). During the past 10 years, enormous progress has been made in our understanding of the mechanisms of induction of apoptosis and the intracellular signal transduction mechanisms activated. These will be reviewed because they give insight into the types of diseases processes in which apoptosis is either excessive or inadequate. By contrast, our knowledge of the role of apoptosis in pediatric gastrointestinal disease is much less developed. We will review current information on the role of apoptosis in gastrointestinal disease highlighting conditions of relevance to pediatric practice. MECHANISMS OF APOPTOSIS The genetics and molecular mechanisms of apoptosis were first described in studies of the nematode worm Caenorhabditis elegans(7). These studies have shown that apoptosis consists of a sequential series of steps controlled by CED genes (C. elegans death genes), which eventually lead to cell death by activation of intracellular cysteine protease (caspase) enzymes. CED-3 and CED-4 are required for the execution of apoptosis whereas the CED-9 gene prevents apoptosis by inhibiting CED-3 and CED-4. The C. elegans model is relevant to higher animals in that these apoptosis genes have been remarkably conserved throughout animal evolution (8–10). These genes have mammalian homologues:CED-3 is a homologue of mammalian caspases, CED-4 is a homologue of apoptotic protease activating factor-1 (APAF-1) and CED-9 is a homologue of Bcl-2. More recently it has been discovered that CED-2 and CED-10 control phagocytosis and cell migration (11). Of particular importance to pediatric practice has been the report that CED-8 controls the timing of cell death and is similar to human XK, a protein implicated in McLeod Syndrome (12). These molecular similarities show that the molecular mechanisms of apoptosis are ancient and extend back to early evolution and that apoptosis is essential for the survival of multicellular organisms. Apoptosis can be activated by a variety of intracellular and extracellular signals and is regulated by inhibitory or inducing factors (13). Epithelial cells in the gastrointestinal tract have a common default pathway ending in apoptosis unless acted on by other external factors, such as the extracellular matrix and surrounding cells. This phenomenon of isolated cell death by apoptosis is extremely important and has been termed anoikis (14). Indeed, many investigators of gastrointestinal epithelial function have had the frustrating experience of having experiments ruined by anoikis of isolated cells. Commitment to death can be specifically triggered by either addition of a death-promoting ligand to the extracellular medium around a cell or by removal of a death-inhibiting ligand. Study of apoptosis in the immune system has been useful in the study of such ligand-induced pathways, although it is now known that these mechanisms also exist in gastrointestinal epithelial cells. The best known of such ligands is Fas ligand (FasL). This is a 40-kd type II transmembrane protein that induces apoptosis by binding to Fas (APO-1 or CD95). Fas is a glycosylated 45-kd type I transmembrane receptor that belongs to the tissue necrosis factor–nerve growth factor receptor family (15). When a T-cell receptor on a cytotoxic T lymphocyte (Tc cell) binds to a foreign peptide presented on the class I major histocompatibility complex of an antigen-presenting cell, it induces the expression of FasL on the surface of the Tc cell. FasL then binds to Fas, a cell surface receptor present on most cells of the body. This results in trimerization of the death domain (the cytoplasmic domain of Fas) and activation of caspase 8 through the adapter molecule Fas-associated protein with death domain (FADD) (16). Caspase 8 then sets off other caspases, resulting in apoptosis of the affected cell (15,17–19). This FasL-mediated apoptosis of activated immunocytes regulates immune responses and contributes to immune privilege in the eye and testis. It is distinct from other apoptotic pathways involving mitochondria (see description later), in that it is not efficiently inhibited by Bcl-2 and in that cytochrome c does not play a role (20). Tc cells can also induce apoptosis by secretion of perforin, a pore-forming protein that, when inserted into the target cell, allows granzyme B to pass through into the target cell (21). This is thought to induce apoptosis by activation of one of the interleukin-1β-converting enzyme (ICE)–like cysteine proteases (22) and a 55-kd effector protein called FLICE (which has a homology and function similar to FADD) (23). These mechanistic insights into the action of T cells show that wherever there is inflammation, apoptosis is likely to be taking place. The removal of a growth factor from its receptor is another example of receptor-mediated apoptosis, although it is now receptor vacancy rather than occupancy that is the trigger (e.g., activated T lymphocytes that are dependent on the soluble protein interleukin (IL)-2. If IL-2 is removed from the medium, then T-lymphocyte apoptosis occurs (18,19,24,25). In many examples of apoptosis, mitochondria act as stress sensors that trigger the destruction of the cell by activating a family of cysteine proteases called caspases (26). This occurs through the release of cytochrome c from the intermembrane space between the inner and outer mitochondrial membranes into the cytosol (27). There, cytochrome c forms a complex with APAF-1, deoxyadenosine triphosphate (dATP), and procaspase 9, which activates the caspase cascade and results in cell death. It is also known that the inner mitochondrial membrane potential collapses early in apoptosis (28–30) and that this is the result of the opening of a mitochondrial permeability pore complex (PTPC). The precise relationship between induction of the PTPC and cytochrome c release in gastrointestinal tissue remains to be established (31). Apoptosis is regulated by the Bcl-2 family of proteins whose members can either induce or inhibit apoptosis (32). These proteins have a wide range of actions including preventing release of mitochondrial cytochrome c in the case of antiapoptotic proteins Bcl-2 and Bcl-xL, or promoting release of cytochrome c, as in the case of the proapoptotic protein Bax. Bcl-2 and Bcl-xL, which are located on the cytoplasmic surface of the outer mitochondria membrane, are also thought to act by directly preventing mitochondrial permeabilization, and therefore apoptosis (27,28,33). Overall, a unifying mechanism explaining all the actions of Bcl-2 family members remains to be found. DNA damage can also cause apoptosis through a number of pathways resulting in caspase activation. The best known involves the nuclear phosphoprotein p53, which is stabilized and activated by DNA damage causing either apoptosis or cell cycle arrest through transactivation of the cyclin-dependent kinase inhibitor p21waf1/cip1 (34). It is not clear how p53 activation initiates apoptosis, but it is thought that its activation leads to the induction of the proapoptotic protein Bax. This in turn localizes to mitochondria, causing release of cytochrome c and thus commitment to cell death by caspase-9 activation (35). ESOPHAGUS The role of apoptosis in esophageal disease remains unclear. To date, there have been few systematic studies of apoptosis in normal esophageal epithelium. In reflux esophagitis, apoptosis is generally increased, probably reflecting the action of Tc cells (36). Aberrant expression of FasL in esophageal squamous cancer may be an important mechanism of creating immune privilege within the tumor. Increased expression of FasL and decreased expression of Fas is observed early in the evolution of esophageal squamous cell carcinomas (37). FasL overexpression by esophageal tumor cell lines has been shown to induce apoptosis of cocultured Fas-sensitive lymphoid tumor-killing cells. O'Connell et al. (38) coined the phrase “Fas counterattack” to describe tumor cells that express FasL, killing invading host T cells before T cells can kill the tumor cells. It is now known that many tumors use this mechanism to evade immune attack. In the Barretts metaplasia-dysplasia-carcinoma sequence Bcl-2 expression is increased, whereas Fas expression is decreased, allowing potential cells to become neoplastic (39,40). This result is difficult to interpret without knowledge of the expression of other members of the Bcl-2 family that could counterbalance the antiapoptotic effects of Bcl-2. So far, a clear role for the absence of apoptosis remains to be established. STOMACH A number of studies have shown that Helicobacter pylori–colonized gastric mucosa contain more apoptotic cells than normal mucosa (41–43). This increased number of apoptotic epithelial cells decreases to normal, after eradication of H. pylori. H. pylori–induced apoptosis is also accompanied by an increased expression of Bak, a proapoptotic member of the Bcl-2 family, with little change in expression of the other Bcl-2 family members (44). Absence of the cytotoxin-associated gene (cagA) pathogenicity island is important for the induction of apoptosis by H. pylori(45). An increase in apoptotic rate may be the stimulus for a compensatory hyperproliferative response in an attempt by the gastric mucosa to maintain cell mass (46). It has been suggested that once hyperproliferation is established, the increased rate of cell cycling may predispose the gastric epithelium to genotoxic damage and mutagenesis (47). Increased Bcl-2 expression is seen in gastric epithelial dysplasia (48) and adenocarcinomas of the high-grade intestinal type (49). Bcl-2 is normally expressed in the proliferating zone of the gastric mucosa (50). Its expression in the gastric carcinoma sequence may predispose proliferative cells to become neoplastic. Human gastric adenocarcinomas also express FasL, resulting in apoptosis of tumor-infiltrating lymphocytes and immune privilege (51). SMALL BOWEL The mechanism of cell shedding from the villus tip is a subject of controversy (6). Apoptotic bodies are rarely seen in the villi of healthy subjects, which suggests that apoptosis is a rare event. In active celiac disease, there are an increased number of apoptotic cells throughout the crypt–villus axis that decreases after a gluten–free diet. It has been suggested that increased apoptosis mediated by the ligation of FasL to Fas receptors on villus epithelial cells is responsible for the villus atrophy (52,53). These studies have relied on the terminal deoxynucleotidyl transferase-deoxyuridine triphosphate (TdT-dUTP) nick-end labeling (TUNEL) method for identifying apoptotic cells, but this assay can be unreliable in intestinal epithelium. Confirmatory studies are needed in which less ambiguous methods of detecting apoptosis are used. Small intestinal cancer is rarer than large bowel cancer. One reason for this disparity may be that stem cells at the base of the crypts of the small intestine are far more sensitive to the induction of apoptosis than stem cells in the large intestine. The reason for this differential sensitivity to apoptosis is not understood but may be partly related to a different distribution of pro-and antiapoptotic members of the Bcl-2 family in the two intestinal segments (54,55). LIVER Normal mouse and human liver constitutively express Fas (56,57). The numbers of hepatocytes showing features of apoptosis are increased in patients with chronic hepatitis B and C (58). There is increasing evidence that Fas is important in the regulation of apoptosis in hepatocytes and in the pathogenesis of liver diseases (59–61). Fas activation in mice has been shown to induce fulminant hepatic failure within hours (62). Indeed, this is a rare example of the occurrence of coordinate apoptosis in a whole-cell population. It is far more common for apoptosis to occur randomly in single cells. Upregulation of Fas has been described in alcoholic cirrhosis, chronic hepatitis B and C, and fulminant hepatic failure (whatever the cause). Hepatic failure and liver cell damage in acute Wilson's disease has now also been shown to involve Fas-mediated apoptosis where Fas upregulation is thought to occur by the oxidative stress of excess copper (63). PANCREAS In the pancreas, failure to delete self-reactive T cells by apoptosis (Fas/FasL pathway) results in destruction of Langerhans' β cells. This process is implicated in the pathogenesis of autoimmune diabetes mellitus (64,65). Recently, it has also been demonstrated that apoptosis occurs in some forms of experimental pancreatitis (66–68). There is some evidence to suggest that in cerulin-induced pancreatitis, apoptosis may cause less organ destruction, protease release, and cytokine activation than necrosis (69). COLON Colorectal adenomas are believed to arise from stem cells at the base of colonic crypts. When considered against the huge number of cell divisions these stem cells undergo in a human lifetime, colorectal carcinogenesis is a rare event. An appealing hypothesis for this disparity is that stem cells with mutant DNA are destroyed by apoptosis before they find a clone with malignant potential. Stem cells that fail to undergo apoptosis after mutation give rise to cancer. It has been reported that colonic epithelial cells become more resistant to apoptosis as they progress along the adenoma–carcinoma sequence (70,71). Further support is given to this hypothesis by the fact that genes and proteins that regulate apoptosis such as the Bcl-2 family, p53, myc, ras, cyclooxygenase (COX)-2, Fas, and FasL are either deleted, mutant, or inappropriately expressed in cancer cells (72). However, it has so far been impossible to follow the fate of individual stem cells after specific mutations to determine whether failure of apoptosis is an important factor in the founding of malignant clones. For example, mutation of p53 is known to be important in the progression of adenoma to carcinoma. However it has been reported that wild-type p53 retards the progression of adenoma to carcinoma by mechanisms independent of apoptosis (73). Increasing numbers of bacterial pathogens have been identified as capable of inducing apoptosis, either by causing host tissue destruction or by evading the host immune response (74,75). Of these Salmonella spp, Shigella spp, and Clostridium difficile all have pathogenic relevance to the lower gastrointestinal tract. Shigella flexneri can induce apoptosis in host macrophages by producing a protein called invasin plasmid antigen B (ipaB). This protein binds directly to caspase 1 (previously known as ICE), causing activation and apoptosis. By this means, the S. flexneri evades the host immune response. This activation of ICE is thought to occur through the action of specific Shigella and Salmonella invasin plasmid antigens (76–80). It has been suggested that this activation of ICE-induced apoptosis in macrophages also results in the extracellular release of the proinflammatory cytokine IL-1β triggering inflammation (75). C. difficile, the causative agent of pseudomembranous colitis, also causes apoptosis, but in epithelial cells rather than invading macrophages. Its toxin A causes colonic inflammation by injuring epithelial cells and inducing the inflammatory cytokine IL-8 causing detachment of epithelial cells from the basement membrane. This detachment from the basement membrane is a potent cause of epithelial apoptosis, as noted earlier (81,82). Apoptosis has a number of potential roles in inflammatory bowel disease. In active ulcerative colitis, apoptosis has been observed along the entire length of the crypts leading to loss of epithelial cells (83). Fas is expressed on the epithelia of the normal colon, which leads to the suggestion that activation of the Fas-FasL pathway may be involved. This Fas-FasL apoptotic pathway is consistent with the suspected immune pathogenesis of this condition but does not appear to be significant in the pathogenesis of Crohn's colitis (84–85). Apoptosis also regulates the immune system by deleting specific cell types. Dysregulation of apoptosis in inflammatory cells could account for inappropriately extended inflammatory responses. It is known that lamina propria T cells have reduced rates of proliferation and cytokine production (86). Apoptosis rates in lamina propria T cells have been reported to be reduced in Crohn's disease because of a relative insensitivity to Fas-induced apoptosis and increased expression of Bcl-2 (87). There are also certain lower gastrointestinal conditions associated with apoptosis that appear drug related. Melanosis coli is caused by anthraquinone abuse and is accompanied by apoptosis of colonocytes (88). Microscopic colitis is a condition characterized by diarrhea, normal endoscopic findings, and mild inflammatory changes of the colonic mucosa (89). Ranitidine, a histamine H2 antagonist, and ticlopidine, an inhibitor of platelet aggregation, have both been reported to cause a microscopic colitis with an associated increase in apoptotic epithelial cells (90,91). CONCLUSION Apoptosis is a fundamental biologic process that can be traced back to primitive multicellular organisms. As such, it is reasonable that abnormal apoptosis leads to disease including that which occurs within the gastrointestinal tract. However, we are in the early stages of understanding its role in these tissues. Current methods for identifying apoptotic cells in histologic sections can be unreliable, particularly when inflammation is severe and apoptotic bodies are interspersed within large areas of necrosis. The difficulty in obtaining primary cultures of intestinal epithelial cells often prevents the design of meaningful functional studies. The use of transgenic and mutant mouse models assumes a special importance in the study of normal and pathologic apoptosis in gastrointestinal epithelium (92). Such an experimental approach may be of particular use in the study of developmental abnormalities of the gastrointestinal organs. Nevertheless, these important insights into disease pathogenesis are likely to yield fruit in new and more specific therapies for gastrointestinal disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Palejwala et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: